Treace Medical Concepts Future Growth
Future criteria checks 1/6
Treace Medical Concepts is forecast to grow earnings and revenue by 17.3% and 15.3% per annum respectively. EPS is expected to grow by 15.4% per annum. Return on equity is forecast to be -56.7% in 3 years.
Key information
17.3%
Earnings growth rate
15.4%
EPS growth rate
| Medical Equipment earnings growth | 16.5% |
| Revenue growth rate | 15.3% |
| Future return on equity | -56.7% |
| Analyst coverage | Good |
| Last updated | 15 Apr 2024 |
Recent future growth updates
Recent updates
Market Still Lacking Some Conviction On Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Apr 05
Does Treace Medical Concepts (NASDAQ:TMCI) Have A Healthy Balance Sheet?
Feb 09Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) 31% Share Price Surge
Jan 04Market Cool On Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Revenues Pushing Shares 46% Lower
Nov 11Analysts Are Updating Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Estimates After Its Second-Quarter Results
Aug 13Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 303 | -41 | -7 | N/A | 6 |
| 12/31/2025 | 263 | -49 | -21 | -15 | 7 |
| 12/31/2024 | 223 | -57 | -29 | -16 | 7 |
| 12/31/2023 | 187 | -50 | -46 | -35 | N/A |
| 9/30/2023 | 175 | -48 | -52 | -40 | N/A |
| 6/30/2023 | 167 | -42 | -52 | -38 | N/A |
| 3/31/2023 | 155 | -47 | -56 | -41 | N/A |
| 12/31/2022 | 142 | -43 | -45 | -31 | N/A |
| 9/30/2022 | 126 | -45 | -42 | -29 | N/A |
| 6/30/2022 | 114 | -39 | -39 | -31 | N/A |
| 3/31/2022 | 105 | -27 | -28 | -24 | N/A |
| 12/31/2021 | 94 | -21 | -20 | -17 | N/A |
| 9/30/2021 | 85 | -12 | -13 | -11 | N/A |
| 6/30/2021 | 78 | -8 | -7 | -6 | N/A |
| 3/31/2021 | 65 | -5 | -5 | -4 | N/A |
| 12/31/2020 | 57 | -4 | -6 | -4 | N/A |
| 12/31/2019 | 39 | -5 | -9 | -8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TMCI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: TMCI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: TMCI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: TMCI's revenue (15.3% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: TMCI's revenue (15.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TMCI is forecast to be unprofitable in 3 years.